News
In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The new dosing schedule with a more gradual titration significantly lowered incidence of ARIA-E in the TRAILBLAZER-ALZ 6 trial.
In the latest quarter, 7 analysts provided ratings for Eli Lilly LLY +1.30% Get Free Report , showcasing a mix of bullish and ...
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.
2d
Zacks Investment Research on MSNCan Mounjaro and Zepbound Drive Another Strong Quarter for Eli Lilly?Mounjaro (for type II diabetes) and Zepbound (for obesity) — remains strong. Despite being on the market for less than three ...
Cantor Fitzgerald cut Eli Lilly’s FY2025 earnings forecast from $21.91 to $21.76 per share. Eli Lilly reported $3.34 per ...
A systematic review of 63 cases found that pyoderma gangrenosum (PG) during pregnancy or postpartum was often misdiagnosed, ...
TOKYO-Nintendo's new Switch 2 videogame machine uses a rare-earth magnet to attach its hand-held controllers to the main console, according to a teardown, highlighting the company's vulnerability to ...
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...
Caitlin Clark is nearly halfway through her second season in the WNBA, and while her sophomore campaign has been impacted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results